CEP
BMY icon

Chicago Equity Partners’s Bristol-Myers Squibb BMY Stock Holding History

Chicago Equity Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.1M Sell
37,645
-750
-2% -$45.8K 0.21% 132
2019
Q4 		$2.46M Buy
38,395
+22,370
+140% +$1.28M 0.14% 214
2019
Q3 		$813K Buy
16,025
+8,710
+119% +$409K 0.04% 555
2019
Q2 		$332K Sell
7,315
-6,760
-48% -$315K 0.01% 786
2019
Q1 		$672K Sell
14,075
-6,465
-31% -$322K 0.03% 607
2018
Q4 		$1.07M Buy
20,540
+5,690
+38% +$306K 0.04% 478
2018
Q3 		$922K Buy
14,850
+9,120
+159% +$541K 0.03% 539
2018
Q2 		$317K Buy
+5,730
New +$309K 0.01% 732
2018
Q1 		– Sell
-3,710
Closed -$227K – 755
2017
Q4 		$227K Hold
3,710
– – 0.01% 702
2017
Q3 		$236K Hold
3,710
– – 0.01% 714
2017
Q2 		$207K Buy
+3,710
New +$202K 0.01% 728
2017
Q1 		– Sell
-291,725
Closed -$17M – 721
2016
Q4 		$17M Buy
291,725
+269,210
+1,196% +$14.7M 0.45% 57
2016
Q3 		$1.21M Buy
22,515
+10,910
+94% +$701K 0.03% 396
2016
Q2 		$854K Sell
11,605
-25
-0.2% -$1.77K 0.02% 422
2016
Q1 		$743K Buy
+11,630
New +$733K 0.02% 402
2015
Q4 		– Sell
-3,725
Closed -$221K – 593
2015
Q3 		$221K Sell
3,725
-1,960
-34% -$124K 0.01% 539
2015
Q2 		$378K Sell
5,685
-8,055
-59% -$531K 0.01% 376
2015
Q1 		$886K Sell
13,740
-75,200
-85% -$4.71M 0.02% 282
2014
Q4 		$5.25M Buy
88,940
+30,560
+52% +$1.72M 0.14% 149
2014
Q3 		$2.99M Buy
+58,380
New +$2.92M 0.08% 189

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Equity Partners's BMY Position: Q1 2020 in Review

Chicago Equity Partners reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2020, selling an estimated $45.8K and leaving 37,645 shares worth $2.1M. The position accounts for 0.21% of the portfolio, ranked #132.

Chicago Equity Partners first reported a position in BMY in Q3 2014 and has held it in 20 quarters since. The position peaked at $17M in Q4 2016. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Chicago Equity Partners held 37,645 shares of Bristol-Myers Squibb worth $2.1M as of Q1 2020.
  • Chicago Equity Partners sold 750 Bristol-Myers Squibb shares in Q1 2020, an estimated $45.8K.
  • Bristol-Myers Squibb made up 0.21% of Chicago Equity Partners's portfolio in Q1 2020, its #132 holding.
  • Chicago Equity Partners first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 20 quarters since.
  • Chicago Equity Partners's Bristol-Myers Squibb position peaked at $17M in Q4 2016.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.